29-year Study shows Long-Term Benefits to Mammography

Article

Mammographic screening sharply lowers the risk of breast cancer death over the long-term, according to a study published online June 28 in the journal Radiology.

Mammographic screening sharply lowers the risk of breast cancer death over the long-term, according to a study published online June 28 in the journal Radiology.

The study, which followed 133,056 women aged 40-74 for 29 years, divided women – all from two Swedish counties –  into groups who received mammography and a control group who did not. The screening period lasted seven years, with women from 40-49 being screened every two years and those 50- 74 every 33 months. 

For every 414 to 519 women undergoing mammogram screenings, one breast cancer death was prevented, found the team led by author Stephen W. Duffy, MSc, of Queen Mary University of London.

"In this study, we've continued to monitor women for nearly three decades and we've found that the longer we look, the more lives are saved," Duffy said in a statement.

The study represents a statistical counterpoint to the U.S. Preventative Task Force’s controversial 2009 recommendation to eliminate routine breast-cancer screening for women in their 40s. Breast Cancer is the second most lethal of cancers among women, behind only lung cancer.

 

 

Recent Videos
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.